1 Market Overview
1.1 Chitosan for Medical Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Chitosan for Medical Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 DAC 85%
1.2.3 DAC 90%
1.2.4 DAC 95%
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Chitosan for Medical Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Dietary Supplements
1.3.3 Medicine
1.3.4 Other
1.4 Global Chitosan for Medical Market Size & Forecast
1.4.1 Global Chitosan for Medical Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Chitosan for Medical Sales in Volume (2017-2028)
1.4.3 Global Chitosan for Medical Price (2017-2028)
1.5 Global Chitosan for Medical Production Capacity Analysis
1.5.1 Global Chitosan for Medical Total Production Capacity (2017-2028)
1.5.2 Global Chitosan for Medical Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Chitosan for Medical Market Drivers
1.6.2 Chitosan for Medical Market Restraints
1.6.3 Chitosan for Medical Trends Analysis
2 Manufacturers Profiles
2.1 Primex
2.1.1 Primex Details
2.1.2 Primex Major Business
2.1.3 Primex Chitosan for Medical Product and Services
2.1.4 Primex Chitosan for Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Qingdao Yunzhou Biochemistry
2.2.1 Qingdao Yunzhou Biochemistry Details
2.2.2 Qingdao Yunzhou Biochemistry Major Business
2.2.3 Qingdao Yunzhou Biochemistry Chitosan for Medical Product and Services
2.2.4 Qingdao Yunzhou Biochemistry Chitosan for Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Norwegian Chitosan AS
2.3.1 Norwegian Chitosan AS Details
2.3.2 Norwegian Chitosan AS Major Business
2.3.3 Norwegian Chitosan AS Chitosan for Medical Product and Services
2.3.4 Norwegian Chitosan AS Chitosan for Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Ningbo Zhenhai Haixin
2.4.1 Ningbo Zhenhai Haixin Details
2.4.2 Ningbo Zhenhai Haixin Major Business
2.4.3 Ningbo Zhenhai Haixin Chitosan for Medical Product and Services
2.4.4 Ningbo Zhenhai Haixin Chitosan for Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 KitoZyme
2.5.1 KitoZyme Details
2.5.2 KitoZyme Major Business
2.5.3 KitoZyme Chitosan for Medical Product and Services
2.5.4 KitoZyme Chitosan for Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 BIO21
2.6.1 BIO21 Details
2.6.2 BIO21 Major Business
2.6.3 BIO21 Chitosan for Medical Product and Services
2.6.4 BIO21 Chitosan for Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Vietnam Food
2.7.1 Vietnam Food Details
2.7.2 Vietnam Food Major Business
2.7.3 Vietnam Food Chitosan for Medical Product and Services
2.7.4 Vietnam Food Chitosan for Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 NovaMatrix
2.8.1 NovaMatrix Details
2.8.2 NovaMatrix Major Business
2.8.3 NovaMatrix Chitosan for Medical Product and Services
2.8.4 NovaMatrix Chitosan for Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Golden-Shell Pharmaceutical
2.9.1 Golden-Shell Pharmaceutical Details
2.9.2 Golden-Shell Pharmaceutical Major Business
2.9.3 Golden-Shell Pharmaceutical Chitosan for Medical Product and Services
2.9.4 Golden-Shell Pharmaceutical Chitosan for Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 YSK
2.10.1 YSK Details
2.10.2 YSK Major Business
2.10.3 YSK Chitosan for Medical Product and Services
2.10.4 YSK Chitosan for Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Weikang Group
2.11.1 Weikang Group Details
2.11.2 Weikang Group Major Business
2.11.3 Weikang Group Chitosan for Medical Product and Services
2.11.4 Weikang Group Chitosan for Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Jiangsu Aoxin Biotechnology
2.12.1 Jiangsu Aoxin Biotechnology Details
2.12.2 Jiangsu Aoxin Biotechnology Major Business
2.12.3 Jiangsu Aoxin Biotechnology Chitosan for Medical Product and Services
2.12.4 Jiangsu Aoxin Biotechnology Chitosan for Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 KIMICA Corporation
2.13.1 KIMICA Corporation Details
2.13.2 KIMICA Corporation Major Business
2.13.3 KIMICA Corporation Chitosan for Medical Product and Services
2.13.4 KIMICA Corporation Chitosan for Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Jiangsu Shuanglin
2.14.1 Jiangsu Shuanglin Details
2.14.2 Jiangsu Shuanglin Major Business
2.14.3 Jiangsu Shuanglin Chitosan for Medical Product and Services
2.14.4 Jiangsu Shuanglin Chitosan for Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Mirae biotech
2.15.1 Mirae biotech Details
2.15.2 Mirae biotech Major Business
2.15.3 Mirae biotech Chitosan for Medical Product and Services
2.15.4 Mirae biotech Chitosan for Medical Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Chitosan for Medical Breakdown Data by Manufacturer
3.1 Global Chitosan for Medical Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Chitosan for Medical Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Chitosan for Medical
3.4 Market Concentration Rate
3.4.1 Top 3 Chitosan for Medical Manufacturer Market Share in 2021
3.4.2 Top 6 Chitosan for Medical Manufacturer Market Share in 2021
3.5 Global Chitosan for Medical Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Chitosan for Medical Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Chitosan for Medical Market Size by Region
4.1.1 Global Chitosan for Medical Sales in Volume by Region (2017-2028)
4.1.2 Global Chitosan for Medical Revenue by Region (2017-2028)
4.2 North America Chitosan for Medical Revenue (2017-2028)
4.3 Europe Chitosan for Medical Revenue (2017-2028)
4.4 Asia-Pacific Chitosan for Medical Revenue (2017-2028)
4.5 South America Chitosan for Medical Revenue (2017-2028)
4.6 Middle East and Africa Chitosan for Medical Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Chitosan for Medical Sales in Volume by Type (2017-2028)
5.2 Global Chitosan for Medical Revenue by Type (2017-2028)
5.3 Global Chitosan for Medical Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Chitosan for Medical Sales in Volume by Application (2017-2028)
6.2 Global Chitosan for Medical Revenue by Application (2017-2028)
6.3 Global Chitosan for Medical Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Chitosan for Medical Sales by Type (2017-2028)
7.2 North America Chitosan for Medical Sales by Application (2017-2028)
7.3 North America Chitosan for Medical Market Size by Country
7.3.1 North America Chitosan for Medical Sales in Volume by Country (2017-2028)
7.3.2 North America Chitosan for Medical Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Chitosan for Medical Sales by Type (2017-2028)
8.2 Europe Chitosan for Medical Sales by Application (2017-2028)
8.3 Europe Chitosan for Medical Market Size by Country
8.3.1 Europe Chitosan for Medical Sales in Volume by Country (2017-2028)
8.3.2 Europe Chitosan for Medical Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Chitosan for Medical Sales by Type (2017-2028)
9.2 Asia-Pacific Chitosan for Medical Sales by Application (2017-2028)
9.3 Asia-Pacific Chitosan for Medical Market Size by Region
9.3.1 Asia-Pacific Chitosan for Medical Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Chitosan for Medical Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Chitosan for Medical Sales by Type (2017-2028)
10.2 South America Chitosan for Medical Sales by Application (2017-2028)
10.3 South America Chitosan for Medical Market Size by Country
10.3.1 South America Chitosan for Medical Sales in Volume by Country (2017-2028)
10.3.2 South America Chitosan for Medical Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Chitosan for Medical Sales by Type (2017-2028)
11.2 Middle East & Africa Chitosan for Medical Sales by Application (2017-2028)
11.3 Middle East & Africa Chitosan for Medical Market Size by Country
11.3.1 Middle East & Africa Chitosan for Medical Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Chitosan for Medical Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Chitosan for Medical and Key Manufacturers
12.2 Manufacturing Costs Percentage of Chitosan for Medical
12.3 Chitosan for Medical Production Process
12.4 Chitosan for Medical Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Chitosan for Medical Typical Distributors
13.3 Chitosan for Medical Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
世界の医療用キトサン市場2022年：DAC 85%、DAC 90%、DAC 95%、その他 |
| 【英語タイトル】Global Chitosan for Medical Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028 | |
 | ・商品コード：GIR22NO2573 ・発行会社（調査会社）：GlobalInfoResearch ・発行日：2022年11月2日（※2025年版があります。お問い合わせください。） ・ページ数：112 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（注文後2-3日） ・調査対象地域：グローバル ・産業分野：化学＆材料 |
| Single User（1名様閲覧用） | USD3,480 ⇒換算￥528,960 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD5,220 ⇒換算￥793,440 | 見積依頼/購入/質問フォーム |
| Corporate User（同一法人内共有可） | USD6,960 ⇒換算￥1,057,920 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 医療用キトサン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の医療用キトサンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 医療用キトサン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・DAC 85%、DAC 90%、DAC 95%、その他 用途別セグメントは次のように区分されます。 ・栄養補助食品、医薬品、その他 世界の医療用キトサン市場の主要な市場プレーヤーは以下のとおりです。 ・Primex、Qingdao Yunzhou Biochemistry、Norwegian Chitosan AS、Ningbo Zhenhai Haixin、KitoZyme、BIO21、Vietnam Food、NovaMatrix、Golden-Shell Pharmaceutical、YSK、Weikang Group、Jiangsu Aoxin Biotechnology、KIMICA Corporation、Jiangsu Shuanglin、Mirae biotech 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、医療用キトサン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な医療用キトサンメーカーの企業概要、2019年～2022年までの医療用キトサンの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な医療用キトサンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別医療用キトサンの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの医療用キトサンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での医療用キトサン市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および医療用キトサンの産業チェーンを掲載しています。 ・第13、14、15章では、医療用キトサンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - 医療用キトサンの概要 - 種類別分析（2017年vs2021年vs2028年）：DAC 85%、DAC 90%、DAC 95%、その他 - 用途別分析（2017年vs2021年vs2028年）：栄養補助食品、医薬品、その他 - 世界の医療用キトサン市場規模・予測 - 世界の医療用キトサン生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Primex、Qingdao Yunzhou Biochemistry、Norwegian Chitosan AS、Ningbo Zhenhai Haixin、KitoZyme、BIO21、Vietnam Food、NovaMatrix、Golden-Shell Pharmaceutical、YSK、Weikang Group、Jiangsu Aoxin Biotechnology、KIMICA Corporation、Jiangsu Shuanglin、Mirae biotech ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：DAC 85%、DAC 90%、DAC 95%、その他 ・用途別分析2017年-2028年：栄養補助食品、医薬品、その他 ・医療用キトサンの北米市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・医療用キトサンのヨーロッパ市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・医療用キトサンのアジア市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・医療用キトサンの南米市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・医療用キトサンの中東・アフリカ市場 - 種類別市場規模2017年-2028年 - 用途別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Chitosan for Medical market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Chitosan for Medical market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Dietary Supplements accounting for % of the Chitosan for Medical global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While DAC 85% segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Chitosan for Medical include Primex, Qingdao Yunzhou Biochemistry, Norwegian Chitosan AS, Ningbo Zhenhai Haixin, and KitoZyme, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Chitosan for Medical market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
DAC 85%
DAC 90%
DAC 95%
Other
Market segment by Application can be divided into
Dietary Supplements
Medicine
Other
The key market players for global Chitosan for Medical market are listed below:
Primex
Qingdao Yunzhou Biochemistry
Norwegian Chitosan AS
Ningbo Zhenhai Haixin
KitoZyme
BIO21
Vietnam Food
NovaMatrix
Golden-Shell Pharmaceutical
YSK
Weikang Group
Jiangsu Aoxin Biotechnology
KIMICA Corporation
Jiangsu Shuanglin
Mirae biotech
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Chitosan for Medical product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Chitosan for Medical, with price, sales, revenue and global market share of Chitosan for Medical from 2019 to 2022.
Chapter 3, the Chitosan for Medical competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Chitosan for Medical breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Chitosan for Medical market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Chitosan for Medical.
Chapter 13, 14, and 15, to describe Chitosan for Medical sales channel, distributors, customers, research findings and conclusion, appendix and data source.
| ★調査レポート[世界の医療用キトサン市場2022年：DAC 85%、DAC 90%、DAC 95%、その他] (コード：GIR22NO2573)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の医療用キトサン市場2022年：DAC 85%、DAC 90%、DAC 95%、その他]についてメールでお問い合わせ |
